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Influenza A(H5N1) Virus Infection in 
a Child With Encephalitis Complicated 
by Obstructive Hydrocephalus
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A 2-year-old boy with highly pathogenic avian influenza 
A(H5N1) virus infection with minimal respiratory symptoms 
developed encephalitis complicated by obstructive hydroceph-
alus. Viral RNA was detectable in cerebrospinal fluid. The virus 
belonged to H5N1 clade 2.3.2.1b and had acquired the mam-
malian adaptation mutation PB2 Q591K.
Keywords. avian influenza; central nervous system infec-
tion; H5N1; hydrocephalus. 
In the past 2 decades, highly pathogenic avian influenza (HPAI) 
A(H5N1) has become entrenched in poultry in a number of 
countries in Asia, the Middle East (eg, Egypt), and West Africa. 
Some clades of H5N1, related H5N8 viruses, and their descend-
ants have been carried by wild-bird migration to Europe and 
North America. The zoonotic and pandemic risks associated 
with these viruses need to be continually monitored [1].
CASE REPORT
A 2-year-old boy developed fever, runny nose, and productive 
cough on 23 May 2012 (day 1 of illness) in Guangdong province. 
He returned to Hong Kong on 26 May and sought outpatient 
medical attention. On 28 May (day 6 of illness), he developed 
convulsions and was admitted to the Caritas Medical Centre 
with a diagnosis of suspected encephalitis. His chest radiograph 
was unremarkable. A  nasopharyngeal aspirate was found to 
be positive for influenza A  by real-time reverse-transcription 
polymerase chain reaction (RT-PCR), negative for H1 and 
H3, and subsequently subtyped to be H5N1 [2]. The child was 
transferred to the Intensive Care Unit of the Infectious Disease 
Centre at Princess Margaret Hospital for isolation and further 
management. Oseltamivir therapy was commenced on 30 May 
(day 8 of illness) at a dose of 60 mg orally twice daily for a child 
weighing 11.9 kg—that is, double the dose recommended for 
uncomplicated influenza. The parents denied consent for a 
lumbar puncture at this stage. Epidemiological investigation 
revealed that the boy had visited a sidewalk wet market with live 
poultry in Guangzhou in mid-May. The boy’s parents remained 
asymptomatic and clinical specimens collected from them were 
negative for influenza A.
Computed tomography of the brain performed on day 6 of 
illness showed no focal lesion and no displacement of midline 
structures, and the ventricles were not dilated (Figure  1A). 
Magnetic resonance imaging of the brain on day 11 of illness 
showed moderate obstructive hydrocephalus with transependy-
mal flow of the cerebrospinal fluid (CSF) evidenced by the dilated 
bilateral lateral ventricles and the third ventricles (Figure  1B). 
The fourth ventricle was not dilated. The level of obstruction was 
at the cerebral aqueduct. An external ventricular catheter was 
inserted to relieve the obstructive hydrocephalus. Examination 
of the drained ventricular CSF on day 11 of illness revealed a red 
blood cell count 242 cells/μL, white blood cell count 165 cells/μL 
with lymphocyte predominance, protein 1.44 g/L, and glucose 
2.4 mmol/L. A small fragment of brain tissue showed histological 
features of meningoencephalitis, and virus RNA was detectable 
at a borderline level (CT39). PCR for herpes simplex virus type 
1 and 2 DNA and RT-PCR for enterovirus RNA were repeatedly 
negative in the CSF specimens and in the brain biopsy.
Serial specimens of CSF, nasopharyngeal aspirate (NPA), 
rectal swab, stool, urine, plasma, and serum were tested by 
real-time quantitative RT-PCR (qPCR) targeting M gene for 
influenza A virus and the hemagglutinin (HA) gene for H5N1 
virus (Supplementary Methods; Table 1). The qPCR assay for 
the H5 gene was more sensitive than for the influenza M gene. 
CSF collected on day 11 and 13 as well as plasma on day 11 had 
detectable viral RNA (M gene and H5 gene), albeit at low viral 
load. In view of detection of virus RNA in CSF, the reported 
low CSF penetration of oseltamivir [3], known good intrathecal 
penetration of amantadine [4], and the virus genetic sequence 
(see below) without known mutations in the M2 gene associated 
with amantadine resistance, oral amantadine therapy (40  mg 
orally twice daily) was added to oseltamivir on day 14 of illness. 
The amantadine dosage was increased to 50  mg orally twice 
daily on day 27. In view of persistence of viral RNA in naso-
pharyngeal aspirates, ribavirin at a dose of 180 mg was given 
intravenously every 6 hours from day 27. The child received 
oseltamivir for 25 days, amantadine for 17 days, and ribavirin 
for 5 days. Given the late commencement of amantadine and 
ribavirin, their therapeutic contribution remains unclear. The 
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ventricular drain was removed on day 35. The child made a 
complete recovery and was discharged from hospital on 5 July 
with satisfactory clinical condition. There were no neurological 
sequelae or developmental delay detected during subsequent 
follow-up.
Levels of monocyte chemoattractant protein 1, monokine 
induced by interferon gamma, and CXCL 10 (interferon gam-
ma-induced protein 10) were assayed on the patient serum and 
CSF collected on day 11 of illness (Supplementary Methods). 
Serum samples from 6 controls (aged 6, 7, 8, 36, 42, and 
47 years, collected from other noninfectious clinical indications 
and anonymized for chemokine testing) were also assayed 
(Supplementary Figure 1).
A madin darby canine kidney cell culture virus isolate des-
ignated A/Hong Kong/5923/2012 (H5N1) (abbreviated to 
H5N1/5923 hereafter) was obtained from an NPA specimen col-
lected on day 6 of illness. The virus was fully genetically sequenced 
and phylogenetic analysis showed that the virus belonged to clade 
2.3.2.1b in all 8 gene segments. The PB1 and PA gene segments 
of clade 2.3.2.1b viruses cluster also with corresponding genes of 
H5N6 viruses (Supplementary Figure 2). The H5N1/5923 virus 
had a Q591K amino acid substitution in the PB2 protein in spec-
imens collected at day 6 and day 11 of illness. The HA1-HA2 
connecting peptide possessed a multibasic amino acid sequence 
(PQIERRRRKR*GLF), which is common in clade 2.3.2.1b H5N1 
viruses and characteristic of HPAI viruses. Mature HA protein 
has amino acid residues E190, Q226, and G228 (H3 number-
ing), indicating an avian-like receptor specificity (Supplementary 
Table) [5]. There were no mutations in the viral neuraminidase 
(NA) or M2 genes associated with resistance to NA inhibitors or 
adamantanes (Supplementary Table). The virus NA and M genes 
from NPA specimens collected on day 15, 17, 19, 21, and 22 of 
illness was also sequenced directly from the clinical specimen, 
and no known resistance mutations to NA inhibitors or adaman-
tanes were detected (Supplementary Table).
DISCUSSION
Patients infected with H5N1 present primarily with acute res-
piratory illness [6]. To our knowledge, there are only 2 other 
case reports of H5N1 infections with major manifestations of 
central nervous system (CNS) disease [7, 8] but neither with 
hydrocephalus. The first was a 4-year-old boy who presented 
with fever, headache, and diarrhea in Vietnam. He had no res-
piratory symptoms at initial admission and had a normal chest 
radiograph. He later developed a cough and had mild crackles 
and wheezing on auscultation. He became drowsy and then 
comatose. CSF examination revealed a moderately elevated 
CSF protein level but no increase in white cells. He progressed 
to respiratory failure and died. The diagnosis was acute enceph-
alitis. Retrospective investigation as part of a study of enceph-
alitis of unknown etiology yielded an influenza A(H5N1) virus 
isolate from the stored CSF specimen. The boy’s sister had died 
of a similar illness a few days previously [7]. A second patient 
was a young adult who presented with multilobar pneumonia 
progressing to diffuse encephalitis, leading to a fatal outcome 
[8].
HPAI H5N1 virus may enter the CNS via the blood circu-
lation. Alternatively, virus from the nasopharynx may traverse 
the cribriform plate and enter the basal subarachnoid space with 
subsequent retrograde spread from the cisterna magna into the 
ventricular CSF space through the foramina of Luschka and 
Magendie. Spread of HPAI H5N1 virus to the brain along the 
olfactory nerves and via the cribriform plate has been reported 
Figure 1. A, Computed tomography of the brain performed on day 6 of illness 
showed no focal lesion and no displacement of midline structures, and the ven-
tricles were not dilated. B, Magnetic resonance imaging of the brain on day 11 of 
illness showed moderate obstructive hydrocephalus with involvement of the lateral 
and third ventricles.
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in experimentally infected ferrets [9]. In this patient, inflamma-
tion resulting in acute ependymitis may have led to obliteration 
of the cerebral aqueduct between the third and fourth ventri-
cles, the narrowest part of the ventricular system, resulting in 
obstructive hydrocephalus.
Patients infected with H5N1 reportedly rarely had detecta-
ble viral RNA in the respiratory tract for >3 weeks [6]. In the 
present study, viral RNA was detected in a patient with H5N1 
from NPA up to day 30 after symptom onset. The RT-PCR cycle 
threshold value may be a useful indicator of response to therapy. 
The serum chemokine levels in the patient at day 11 after onset 
of illness were not markedly different to controls. Previous 
studies have reported that chemokine levels were higher in fatal 
rather than nonfatal patients with H5N1 disease [10, 11]. In 
this patient, pathology was primarily in the CNS rather than 
the lung; it is therefore interesting that the chemokine level in 
the patient’s CSF was markedly elevated in comparison to the 
level in the serum sample collected on the same day, providing 
additional evidence of inflammation within the CNS compart-
ment (Supplementary Figure 1).
Previous studies have shown that specific amino acid substi-
tutions in PB2 of avian influenza viruses enhance replication 
competence in mammalian cells and are recognized mam-
malian adaptation markers. In contrast to other clade 2.3.2.1 
H5N1 viruses, the H5N1/5923 virus from our patient had a PB2 
Q591K mutation. This amino acid substitution has been shown 
to increase the replication and pathogenicity of avian H5N1, 
H9N2, and H7N9 viruses in mammals in a manner analo-
gous to previously reported mammalian adaptation signatures 
E627K and D701N [12, 13]. However, while the PB2-E627K 
mediates the virus dissemination to the brain after infection, a 
similar role for PB2-Q591K has not yet been reported in exper-
imental mammalian models, although this remains plausible.
The genetic analysis of the virus HA suggests that the virus 
had a preference for binding α(2–3)–linked sialic acids found 
in avian species. Adult humans have a preponderance of α(2-
6)–linked sialic acids in their upper respiratory tract, and H5N1 
virus disease is believed to take place when the virus gains access 
to the alveolar epithelium where α(2-3)–linked sialic acids are 
present. However, it has been reported that young children 
Table 1. Serial Specimens Collected and Virological Results Obtained
Days Ill
RT-PCR Result (Cycle Threshold Value)
Clinical Comments
NPA
Rectal Swab/ 
Feces CSF Brain Tissue Urine Serum/Plasma
M Gene H5 M Gene H5 M Gene H5 M Gene H5 M Gene H5 M Gene H5
6 + (25.6)a + (24.2) + (41.1) –
8 – – Commence oseltamivir
11 + (30.9)a + (28.6) + (42.8) + (37.3) - + (39.0) + (41.1) + (39.0) Ventricular catheter inserted, CSF 
sampled
12 – –
13 + (30.3)a + (28.2) + (40.9) + (37.9) – –
14 + (38.0) + (34.1) – – – – – – – – Commence amantadine
15 + (27.7) + (27.4) – – – – – –
16 + (33.1) + (31.3) – – + (41.6) – – –
17 + (29.9) + (27.9) – – – – – –
18 + (39.7) + (36.4)
19 + (30.7) + (29.2) – –
20 + (35.9) + (34.3) – –
21 + (31.2) + (28.8)
22 + (30.0) + (28.2) – + (40.0) – –
23 + (38.9) + (38.4) – –
24 + (38.1) + (37.1) – – – –
25 + (34.6) + (34.0)
26 + (36.8) + (34.1)
27 – – – – Commence ribavirin
28 + (37.9) + (34.9)
29 + (41.0) + (37.7)
30 + (38.9) + (37.7)
31 + (42.9) + (38.9)
34 – –
35 Ventricular catheter removed
All specimens except for serum and plasma were also cultured for virus isolation. Cycle threshold value is inversely proportional to virus RNA load.
Abbreviations: +, positive; –, negative; CSF, cerebrospinal fluid; NPA, nasopharyngeal aspirate; RT-PCR, reverse-transcription polymerase chain reaction.
aIndicates virus isolate obtained.
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differ in this respect and have a preponderance of α(2-3)–linked 
sialic acids in their upper respiratory tract [14]. These findings 
need independent confirmation. However, it is interesting to 
speculate whether this may have predisposed this child to infec-
tion with this avian virus infecting the upper respiratory tract 
and subsequently passing via the cribriform plate to invade the 
CNS. In this patient, it is possible that host (young age, genetic 
susceptibility) or viral determinants, or both, contributed to the 
unusual CNS manifestations.
In conclusion, we report influenza A(H5N1) infection in a 
child presenting as encephalitis and progressing to obstructive 
hydrocephalus, preceded by mild upper respiratory symptoms. 
In many instances, such patients may be primarily investigated 
for typical causes of CNS disease rather than for influenza 
A. This case report highlights the need to have a high index of 
suspicion and the need to investigate patients with CNS disease 
for HPAI H5N1 in areas where this virus is endemic in poultry 
and in travelers returning from such areas, even when respira-
tory symptoms are not the prominent presenting feature.
Supplementary Data
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